| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/10/2008 | CA2674345A1 Vaccine |
| 07/10/2008 | CA2674239A1 Methods and vectors for generating asialylated immunoglobulins |
| 07/10/2008 | CA2674188A1 Treatment of prdc in pigs |
| 07/10/2008 | CA2674140A1 Method of providing disease-specific binding molecules and targets |
| 07/10/2008 | CA2674042A1 Non-specific immunostimulating agents |
| 07/10/2008 | CA2674007A1 Process for manufacturing vaccines |
| 07/10/2008 | CA2673969A1 Compositions comprising a b subunit of shiga toxin and a means stimulating nkt cells |
| 07/10/2008 | CA2673870A1 Compositions and methods for the treatment of infections and tumors |
| 07/10/2008 | CA2673868A1 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 07/10/2008 | CA2672933A1 Method of treating cancer by a combined therapy of anticancer agents |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942181A1 Bacterium causing poultry disease and vaccine derived thereof |
| 07/09/2008 | EP1942108A1 Compound containing basic group and use thereof |
| 07/09/2008 | EP1941909A1 Preventives/remedies for cancer |
| 07/09/2008 | EP1941908A1 Therapeutic agent for heart disease |
| 07/09/2008 | EP1941907A1 Inhibitor of transplanted islet dysfunction in islet transplantation |
| 07/09/2008 | EP1941905A1 APO-2 Ligand-anti-her-2 antibody synergism |
| 07/09/2008 | EP1941904A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases |
| 07/09/2008 | EP1941903A1 Prophylaxis and treatment of PRDC |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1941278A2 Optimal polyvalent vaccine for cancer |
| 07/09/2008 | EP1941275A2 Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells |
| 07/09/2008 | EP1941033A2 Compositions and methods for the treatment of canine influenza virus disease |
| 07/09/2008 | EP1941024A2 Attenuated salmonella enterica serovar paratyphi a and uses thereof |
| 07/09/2008 | EP1940881A2 Compositions comprising cross-species-specific antibodies and uses thereof |
| 07/09/2008 | EP1940880A2 Treating diabetes using inhibitors of il-1 |
| 07/09/2008 | EP1940867A2 Hiv gp120 crystal structure and its use to identify immunogens |
| 07/09/2008 | EP1940864A2 Method for generating anti-variable region monoclonal antibodies |
| 07/09/2008 | EP1940466A2 Anti-addl monoclonal antibody and use thereof |
| 07/09/2008 | EP1940465A2 Novel use of il-1beta compounds |
| 07/09/2008 | EP1940464A1 Hexosylceramides as adjuvants and their uses in pharmaceutical compositions |
| 07/09/2008 | EP1940463A2 Method for enhancing immune responses in mammals |
| 07/09/2008 | EP1940462A2 Conjugate vaccines |
| 07/09/2008 | EP1940461A2 Concurrent chemotherapy and immunotherapy |
| 07/09/2008 | EP1940460A2 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof |
| 07/09/2008 | EP1940436A1 Methods for treating immune mediated neurological diseases |
| 07/09/2008 | EP1940414A2 Anti mineralocorticoid therapy of infection |
| 07/09/2008 | EP1715890B1 Ctgf as target for the therapy of microalbuminuria in patients with diabetic nephropathy |
| 07/09/2008 | EP1535627B1 Recombinant bcg vaccine |
| 07/09/2008 | EP1404362B1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 07/09/2008 | EP1403281B1 Novel ligand and dna thereof |
| 07/09/2008 | EP1381345B1 Delivery of disease control in aquaculture using yeasts containing bioactive proteins |
| 07/09/2008 | EP1233784B1 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 07/09/2008 | EP1226177B1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/09/2008 | EP1156820B1 Use of vascular endothelial growth factor-2 (vegf-2) |
| 07/09/2008 | EP1019084B1 Novel antimicrobial polypeptide and methods of use |
| 07/09/2008 | EP1011721B1 Vaginal lactobacillus medicant |
| 07/09/2008 | EP0476130B1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 07/09/2008 | CN101218351A Anti-CD19 antibodies and uses in oncology |
| 07/09/2008 | CN101218341A Use of NK cell inhibition to facilitate persistence of engrafted MHC-I negative cells |
| 07/09/2008 | CN101218257A GITR binding molecules and uses therefor |
| 07/09/2008 | CN101218256A Antibodies against cd38 for treatment of multiple myeloma |
| 07/09/2008 | CN101218254A Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor |
| 07/09/2008 | CN101218253A Cardiovascular disease therapies |
| 07/09/2008 | CN101218252A Use of PANTON-VALENTINE leukocidin for treating and preventing staphylococcus infections |
| 07/09/2008 | CN101218251A 异二聚体蛋白结合组合物 Heterodimeric protein binding compositions |
| 07/09/2008 | CN101217980A New combination of anti-MADCAM antibody and antifibrotic caspase inhibitor to treat liver fibrosis |
| 07/09/2008 | CN101217979A 自缓冲蛋白制剂 Since the buffer protein preparations |
| 07/09/2008 | CN101217978A Methods for treating osteoarthitis pain by administering a nerve growth factor antagonist and compositions containing the same |
| 07/09/2008 | CN101217977A Thermoreversible immuno-adjuvant emulsion |
| 07/09/2008 | CN101217976A Vaccine |
| 07/09/2008 | CN101217975A Vaccine |
| 07/09/2008 | CN101217974A 支原体亚单位疫苗 Mycoplasma subunit vaccines |
| 07/09/2008 | CN101217973A Enhanced activity of HIV vaccine using a second generation immunomodulatory oligonucleotide |
| 07/09/2008 | CN101215576A Rabbit viral haemorrhagic virus capsid protein gene recombination baculovirus and bacterin |
| 07/09/2008 | CN101215575A Rabbit viral haemorrhagic virus capsid protein gene recombination adenovirus and bacterin |
| 07/09/2008 | CN101215568A Anthrax resisting polypeptide and its application and preparation method |
| 07/09/2008 | CN101215552A F-genetype parotitis attenuated virus strain and use thereof |
| 07/09/2008 | CN101215544A Inflammation-inhibiting compounds |
| 07/09/2008 | CN101215332A CRIPTO blocking antibodies and uses thereof |
| 07/09/2008 | CN101214378A Yam polysaccharide complex immunity globulin anti-infectious preparations and preparation thereof |
| 07/09/2008 | CN101214377A Pig immunoglobulinlg oral liquid and preparation thereof |
| 07/09/2008 | CN101214376A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 07/09/2008 | CN101214375A Improved vaccines |
| 07/09/2008 | CN101214369A Polypeptide medicament for treating tumor caused by human papillomavirus type 18 or vaccine |
| 07/09/2008 | CN100400659C Component of bromelain |
| 07/09/2008 | CN100400547C Human monoclonal antibodies to prostate specific membrane antigen |
| 07/09/2008 | CN100400546C Cell surface molecule mediating cell adhesion and signal transmission |
| 07/09/2008 | CN100400102C New vaccine adjuvant |
| 07/09/2008 | CN100400101C Vaccines containing ribavirin and methods of use thereof |
| 07/09/2008 | CN100400100C Methods for preventing or attenuating patthoangiogenic conditions |
| 07/09/2008 | CN100400099C Recombinant protein vaccine for preventing and treating human prostata cancer |
| 07/08/2008 | US7396914 SARS nucleic acids, proteins, antibodies, and uses thereof |
| 07/08/2008 | US7396913 Erythropoietin receptor binding antibodies |
| 07/08/2008 | US7396911 Preventing, treating, or ameliorating human immunodeficiency virus infection |
| 07/08/2008 | US7396910 Transient receptor potential channel TRPV3 and its use |
| 07/08/2008 | US7396909 Toxoplasma gondii proteins |
| 07/08/2008 | US7396810 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
| 07/08/2008 | US7396652 Chemokine PANEC-2 polypeptides and compositions and methods related thereto |
| 07/08/2008 | US7396536 Parasitic helminth cuticlin proteins and uses thereof |
| 07/08/2008 | US7396535 Therapy for obsessive compulsive head banging |
| 07/08/2008 | US7396533 Polypeptides and nucleic acids encoding same |
| 07/08/2008 | US7396532 Administering polypeptide which elicits immune response; antibodies useful as probes for detection; vaccines |
| 07/08/2008 | US7396531 Preventive and therapeutic use of polypeptides from African Swine virus as vaccines |
| 07/08/2008 | US7396530 by integrin (anti-CD11a antibody/efalizumab) antagonist; synergistic with cyclosporine, isotretinoin, etretinate, corticosteroids, fumaric acid esters, dapsone, niacinamide, low-dose chlorambucil, clofazimine or immunosuppressive agent; side effect reduction, rapid improvement |
| 07/08/2008 | CA2675451A1 Combination therapy with angiogenesis inhibitors |
| 07/08/2008 | CA2395077C Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 07/08/2008 | CA2359354C Medicament for the treatment, prevention and diagnosis of infection due to chlamydia pneumoniae |
| 07/08/2008 | CA2339384C Improved method for targeted topical treatment of disease |
| 07/08/2008 | CA2301587C Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof |